Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
AI 90-DAY FORECAST
BULLISH SIGNAL DETECTED
██.█% Sign up free to reveal

Resmed Inc (RSMDF) AI Forecast

Our AI detected a significant signal for Resmed Inc. Create a free account to see the exact price target.

Free account • 30-day free trial

$RSMDF Bullish Signal Full forecast available

Resmed Inc (RSMDF) AI Stock Price Forecast & Investment Analysis

Resmed Inc Stock Price Chart and Technical Analysis

Loading chart...

Resmed Inc (RSMDF) - Comprehensive Stock Analysis & Investment Research

Deep dive into Resmed Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on April 4, 2026, 3:04 a.m. (UTC)

Resmed Inc Investment Summary

When evaluating whether Resmed Inc (RSMDF) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Resmed Inc (RSMDF) operates within the Industrial Applications and Services sector, specifically in the Surgical & Medical Instruments & Apparatus industry. . With a market capitalization of $4 billion, the company is a mid-cap stock that typically offers a balance between growth potential and established business operations.

Financial Performance Analysis

Our comprehensive financial analysis covers Resmed Inc's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Resmed Inc along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Resmed Inc is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Resmed Inc

Sign Up Free
Corporate Identity

Resmed Inc (Stock Symbol: RSMDF) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Surgical & Medical Instruments & Apparatus industry. The company's shares are publicly traded on the NYSE exchange.

Leadership & Workforce

Detailed information about Resmed Inc's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Resmed Inc...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Resmed Inc...

Unlock Full Company Profile

Get complete details about Resmed Inc

Sign Up Free
Revenue & Growth Analysis

Resmed Inc generates annual revenues of $5 billion , indicating a well-established business with proven market demand.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Resmed Inc...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Resmed Inc...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Resmed Inc...

Unlock Financial Analysis

Get complete financial metrics for Resmed Inc

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Resmed Inc's AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial

30-day free trial • Cancel anytime

Strategic Market Position

Resmed Inc strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace. As a mid-cap company, it occupies an attractive position balancing growth potential with established operations. Mid-caps often represent the 'sweet spot' for investors seeking companies that have proven their business models but still have meaningful runway for expansion. These companies are large enough to have competitive advantages but nimble enough to adapt quickly to market changes.

Industry Competitive Landscape

Resmed Inc competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency
Margin & Pricing Power Analysis

The company maintains a 61.7% gross margin which reflects exceptional pricing power and/or an asset-light business model. Gross margins at this level are typically seen in software, pharmaceuticals, or luxury goods companies where the cost of incremental production is minimal relative to selling prices. Such margins indicate significant competitive advantages protecting the company from price-based competition.

Operating margin of 23.5% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. This strong operating margin indicates excellent cost control and efficient organizational structure relative to the revenue base.

Financial Strength & Leverage

Resmed Inc (RSMDF) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Resmed Inc stock analysis.

Deep dive into Resmed Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Resmed Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Resmed Inc: With a P/E ratio of 2.66, the market sees the stock as potentially undervalued.

P/E Ratio 2.66x
P/B Ratio 0.62x
Market Cap $3.82B
Dividend Yield 9.16%
EPS $9.55
Book Value/Share $41.97
Revenue/Share $36.02
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Resmed Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Resmed Inc:

Gross Margin 61.7%
Operating Margin 23.5%
Net Margin 20.1%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Resmed Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Resmed Inc:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Resmed Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Resmed Inc:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Resmed Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Resmed Inc:

Understanding Financial Statement Data

What these metrics mean: Key figures from Resmed Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Resmed Inc: With annual revenue of $5257M, Resmed Inc operates at significant scale.

Income Statement
Total Revenue $5.26B
Operating Income $265M
Net Income $226M
R&D Expense $79M
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Dividends Per Share $2.12
Payout Ratio 0.3%
Shares Outstanding 146M
Growth Metrics (YoY)
EPS Growth 5.5%

Latest Resmed Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Resmed Inc (RSMDF) stock price and investment outlook.

📰 We are currently updating our news feed for Resmed Inc. Check back soon for the latest market analysis and company updates.

Resmed Inc Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Resmed Inc against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Adagio Medical Holdings, Inc. ADGM ██% $27M x 2.2x
Aethlon Medical Inc AEMD ██% $3M -0.1x 0.5x
Acutus Medical, Inc. AFIB ██% $0.00M 0.0x -0.4x
Allurion Technologies, Inc. ALUR ██% $12M -0.4x -0.3x
Autonomix Medical, Inc. AMIX ██% $4M x 0.5x
Angiodynamics Inc ANGO ██% $430M -1.4x 2.5x
Anika Therapeutics, Inc. ANIK ██% $209M -4.3x 1.5x
Artivion, Inc. AORT ██% $1.55B 158.6x 3.5x
Apyx Medical Corp APYX ██% $153M -3.5x 10.5x
Accuray Inc ARAY ██% $46M 4.5x 0.7x
Alphatec Holdings, Inc. ATEC ██% $1.68B -7.4x 135.3x
Atricure, Inc. ATRC ██% $1.42B -39.6x 2.9x
Nuo Therapeutics, Inc. AURX ██% $75M x 77.9x
Avita Medical, Inc. AVHHL ██% $22M x x
Baxter International Inc BAX ██% $8.61B -94.9x 1.4x
Beta Bionics, Inc. BBNX ██% $450M x 1.6x
Becton Dickinson & Co BDX ██% $56.54B 32.2x 2.2x
Heartbeam, Inc. BEAT ██% $50M -5.7x 19.3x
Bluejay Diagnostics, Inc. BJDX ██% $2M -0.5x 0.3x
Boston Scientific Corp BSX ██% $91.78B 31.7x 3.8x
Biotricity Inc. BTCY ██% $7M -2.7x 2.5x
Bioventus Inc. BVS ██% $610M 26.8x 3.3x
Brainsway Ltd. BWAY ██% $537M x x
Carlsmed, Inc. CARL ██% $256M x 2.6x
Cerus Corp CERS ██% $359M -13.8x 5.6x
Clearpoint Neuro, Inc. CLPT ██% $272M -23.5x 9.7x
Co-Diagnostics, Inc. CODX ██% $3M -0.7x 0.2x
Cytosorbents Corp CTSO ██% $34M -1.8x 5.8x
Cvrx, Inc. CVRX ██% $236M -5.5x 6.0x
Delcath Systems, Inc. DCTH ██% $334M 123.7x 3.0x
Dih Holding Us, Inc. DHAI ██% $70K x -0.3x
Dariohealth Corp. DRIO ██% $56M 0.6x 0.8x
Alpha Tau Medical Ltd. DRTS ██% $621M x 8.1x
Dexcom Inc DXCM ██% $23.94B 28.6x 8.7x
Dynatronics Corp DYNT ██% $540K -0.2x 0.2x
Ebr Systems, Inc. EBRCZ ██% $215M x 8.4x
Encision Inc ECIA ██% $2M x 1.2x
Embecta Corp. EMBC ██% $520M 3.7x -0.8x
Electromedical Technologies, Inc EMED ██% $750K x x
Femasys Inc FEMY ██% $25M -1.4x 4.2x
Family Office Of America, Inc. FOFA ██% $48M x 59.5x
Glucotrack, Inc. GCTK ██% $720K 0.9x 0.3x
Global Innovative Platforms Inc. GIPL ██% $320K x 2.0x
Glaukos Corp GKOS ██% $6.48B -46.3x 9.9x
Globus Medical Inc GMED ██% $11.86B 22.1x 2.6x
Fractyl Health, Inc. GUTS ██% $71M x 7.5x
Haemonetics Corp HAE ██% $2.63B 15.0x 2.9x
Harvard Apparatus Regenerative Technology, Inc. HRGN ██% $29M x 27.9x
Heartflow, Inc. HTFL ██% $2.09B x 7.0x
Integra Lifesciences Holdings Corp IART ██% $734M 200.2x 0.7x
Icecure Medical Ltd. ICCM ██% $24M x 2.7x
Seastar Medical Holding Corp ICU ██% $88M -1.1x 7.7x
Icu Medical Inc/De ICUI ██% $3.09B 4223.3x 1.5x
Interpace Biosciences, Inc. IDXG ██% $56M 2.3x 2.5x
Inspira Technologies Oxy B.H.N. Ltd IINN ██% $20M x 8.5x
Inspira Technologies Oxy B.H.N. Ltd IINNW ██% $7M x 1.5x
Intelligent Bio Solutions Inc. INBS ██% $6M -0.3x 0.6x
Infusystem Holdings, Inc INFU ██% $169M 30.5x 3.0x
Inspire Medical Systems, Inc. INSP ██% $1.53B 10.5x 2.0x
Iradimed Corp IRMD ██% $1.23B 54.9x 13.0x
Irhythm Holdings, Inc. IRTC ██% $3.82B -20.2x 25.0x
Invo Fertility, Inc. IVF ██% $18M x 3.1x
Orthopediatrics Corp KIDS ██% $409M -20.7x 1.2x
Kestra Medical Technologies, Ltd. KMTS ██% $1.17B x 4.1x
Koru Medical Systems, Inc. KRMD ██% $198M -19.8x 11.6x
Lemaitre Vascular Inc LMAT ██% $2.48B 42.9x 6.3x
Lensar, Inc. LNSR ██% $72M -6.7x 14.7x
Lucid Diagnostics Inc. LUCD ██% $196M -0.6x 17.9x
Pulmonx Corp LUNG ██% $53M -4.3x 1.0x
Lyra Therapeutics, Inc. LYRA ██% $870K -0.1x 0.5x
Microbot Medical Inc. MBOT ██% $159M -1.3x 2.1x
Mountain Crest Acquisition Corp. V MCAG ██% $34M x 1509.8x
Mountain Crest Acquisition Corp. V MCAGU ██% $31M x -9.9x
Spectral Ai, Inc. MDAI ██% $44M -1.3x 30.8x
Medinotec Inc. MDNC ██% $59M 25.1x 10.7x
Mimedx Group, Inc. MDXG ██% $585M 12.0x 2.3x
Monogram Technologies Inc. MGRM ██% $217M -10.7x 25.1x
Meihua International Medical Technologies Co., Ltd. MHUA ██% $151M x 0.9x
3m Co MMM ██% $77.02B 23.7x 16.4x
Merit Medical Systems Inc MMSI ██% $4.05B 31.6x 2.6x
Modular Medical, Inc. MODD ██% $25M -2.1x 4.3x
Nephros Inc NEPH ██% $32M 26.4x 3.1x
Neuroone Medical Technologies Corp NMTC ██% $40M -1.7x 6.3x
Neuropace Inc NPCE ██% $492M -10.4x 25.9x
Inspiremd, Inc. NSPR ██% $68M -4.3x 1.2x
Nu-Med Plus, Inc. NUMD ██% $930K x 4.8x
Novocure Ltd NVCR ██% $1.18B -20.8x 3.5x
Envveno Medical Corp NVNO ██% $7M x 0.3x
Nexgel, Inc. NXGL ██% $5M -6.8x 1.1x
Nyxoah Sa NYXH ██% $136M x x
Orchestra Biomed Holdings, Inc. OBIO ██% $248M -3.4x 4.6x
Odyssey Health, Inc. ODYY ██% $6M x 0.8x
Orthofix Medical Inc. OFIX ██% $459M -5.8x 1.0x
Osr Holdings, Inc. OSRH ██% $16M x 0.2x
Orasure Technologies Inc OSUR ██% $215M 17.1x 0.6x
Pavmed Inc. PAVM ██% $15M 36.5x 0.4x
Pro Dex Inc PDEX ██% $164M 14.4x 3.9x
Penumbra Inc PEN ██% $12.90B 72.6x 9.0x
Petvivo Holdings, Inc. PETV ██% $24M -1.4x 7.1x
Profusa, Inc. PFSA ██% $790K x x
Polyrizon Ltd. PLRZ ██% $20M x 1.0x
Pulse Biosciences, Inc. PLSE ██% $1.56B -2.6x 19.4x
Picard Medical, Inc. PMI ██% $71M x 18.8x
Insulet Corp PODD ██% $14.57B 59.0x 9.6x
Procept Biorobotics Corp PRCT ██% $1.43B -45.4x 3.9x
Premier Air Charter Holdings Inc. PREM ██% $2M x 2.1x
Profound Medical Corp. PROF ██% $237M x 3.6x
Plus Therapeutics, Inc. PSTV ██% $28M -0.3x 7.1x
Polypid Ltd. PYPD ██% $80M x 7.3x
Avita Medical, Inc. RCEL ██% $115M -5.0x 25.2x
Vivos Inc RDGL ██% $41M x 24.6x
Resmed Inc RMD ██% $32.46B 21.9x 5.1x
Resmed Inc RSMDF ██% $3.82B 2.7x 0.6x
Retinalgenix Technologies Inc. RTGN ██% $60M x x
Retractable Technologies Inc RVP ██% $20M -0.9x 0.3x
Sight Sciences, Inc. SGHT ██% $196M -3.7x 3.1x
Si-Bone, Inc. SIBN ██% $568M -14.3x 3.2x
Sigyn Therapeutics, Inc. SIGY ██% $50K x 0.1x
Sintx Technologies, Inc. SINT ██% $10M x 3.4x
Beauty Health Co SKIN ██% $118M -1.8x 1.9x
Sonoma Pharmaceuticals, Inc. SNOA ██% $4M -5.6x 1.2x
Sanuwave Health, Inc. SNWV ██% $146M 12.4x 90.3x
Solventum Corp SOLV ██% $11.16B 7.2x 2.2x
Sensus Healthcare, Inc. SRTS ██% $68M 31.6x 1.4x
Ss Innovations International, Inc. SSII ██% $1.01B x 26.4x
Strata Skin Sciences, Inc. SSKN ██% $1M -8.0x 0.5x
Neuronetics, Inc. STIM ██% $103M -1.0x 4.6x
Stimcell Energetics Inc. STME ██% $7M x 1152.5x
Sharps Technology Inc. STSS ██% $47M -2.5x 0.2x
Stevanato Group S.P.A. STVN ██% $3.77B x x
Stryker Corp SYK ██% $125.90B 38.8x 5.6x
Tactile Systems Technology Inc TCMD ██% $552M 28.9x 2.5x
Tela Bio, Inc. TELA ██% $25M -1.8x 4.0x
Teleflex Inc TFX ██% $5.26B 31.0x 1.7x
Trisalus Life Sciences, Inc. TLSI ██% $260M -3.6x 28.5x
Trisalus Life Sciences, Inc. TLSIW ██% $62M x -1.9x
Treace Medical Concepts, Inc. TMCI ██% $89M -7.5x 1.0x
Tandem Diabetes Care Inc TNDM ██% $1.28B -17.1x 8.3x
Tenon Medical, Inc. TNON ██% $8M -0.3x 1.5x
T2 Biosystems, Inc. TTOO ██% $210K 0.0x -0.3x
Ufp Technologies Inc UFPT ██% $1.46B 21.4x 3.5x
Qhslab, Inc. USAQ ██% $9M 20.2x 5.7x
Utah Medical Products Inc UTMD ██% $200M 17.8x 1.7x
Venus Concept Inc. VERO ██% $560K 0.0x 0.2x
Catheter Precision, Inc. VTAK ██% $2M x 0.3x
Vivos Therapeutics, Inc. VVOS ██% $15M x 5.8x
Vycor Medical Inc VYCO ██% $3M x 36.9x
West Pharmaceutical Services Inc WST ██% $18.28B 37.0x 5.8x
Beyond Air, Inc. XAIR ██% $7M -0.3x 0.9x
Xtant Medical Holdings, Inc. XTNT ██% $72M 14.4x 1.4x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Resmed Inc Stock Forecast

How accurate are Resmed Inc stock predictions?

Our AI model shows a -10% Spearman correlation coefficient for RSMDF predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Resmed Inc stock price forecasts?

Our analysis considers Resmed Inc's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Resmed Inc a good investment in 2025?

Based on our AI analysis, Resmed Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Resmed Inc forecasts updated?

Resmed Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Resmed Inc?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...